Connect your AI

Organon OGN Total Current Assets

Total Current Assets at other companies

PfizerPFE

$42.82B-6.6%

AmgenAMGN

$31.48B+16.9%

The Cooper Companies, Inc.COO

$2.3B+8.2%

BiogenBIIB

$9.19B+20.5%

AbbVieABBV

$33.53B+21.2%

Amneal Pharmaceuticals, Inc.AMRX

$1.8B+19.0%

Other financials

Income statement

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

Market cap$3.53B-59.4%

Enterprise value$10.98B-26.4%

P/E6.6×+2.1×

P/S0.6×-0.8×

Profitability

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organon's total current assets?: Organon (OGN) reported total current assets of $4.93B in Q1 2026.
How has Organon's total current assets changed year-over-year?: Organon's total current assets increased by 12.8% year-over-year, from $4.37B to $4.93B.
What is the long-term trend for Organon's total current assets?: Over 5 years (2020 to 2025), Organon's total current assets has grown at a 4.1% compound annual growth rate (CAGR), from $3.57B to $4.35B.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.